GSK Pays $2.6M To Exit Idaho Drug Price-Fixing Suit

Law360, Los Angeles (April 17, 2012, 10:16 PM EDT) -- GlaxoSmithKline PLC on Tuesday agreed to pay $2.6 million to resolve Idaho's claims that the drug giant sold its products at inflated prices, the 14th settlement the state has reached with prescription drugmakers since 2005.

GSK is one of several drugmakers targeted over inflated drug prices in lawsuits brought by state attorneys general across the country. The attorneys general say their states' Medicaid programs used drugmakers' allegedly inflated prices to calculate how much to reimburse pharmacies for prescription drugs.

An Idaho federal court has approved GSK's...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.